SARS-CoV-2 Detection RT-PCR Testing Kit
QuantuMDx’ SARS-CoV-2 RT-PCR Detection assay is a real-time reverse transcriptase (rtRT)-PCR assay that has been developed using advanced bioinformatics to maximise performance. The assay has been designed with the most up-to-data sequence information to ensure 100% inclusivity of all known SARS-CoV-2 sequences. The assay is also re-evaluated in silico on a periodic basis to ensure 100% inclusivity versus all available SARS-CoV-2 sequences.
Our SARS-CoV-2 assay has been CE-IVD marked under the in vitro Diagnostics Directive (98/79/EC). We have also applied to the US Food and Drug Administration (FDA) for Emergency Use Authorisation and to the WHO for Emergency Use Listing.
FIND Diagnostics have independently evaluated our assay at the University Hospitals of Geneva, to verify the limit of detection (LOD) and the clinical performance in comparison to an in-house PCR protocol.
Key Features & Benefits
Speed
Amplification & Detection Only
Result in 75 mins or less
(instrument dependent)
Exclusivity
No Cross-reactivity or Interference
No cross-reactivity or interference due to common commensal or infectious organisms found in the respiratory tract, both in silico and standard bench testing
Inclusivity
100% Coverage
100% coverage of all known SARS-CoV-2 sequences at the date of analysis
Sensitive
Amplification & Detection Only
Highly sensitive, targeting three loci
Versatile
Multiple Platforms
Validated to run on multiple platforms
Cost Effective
Competitive
Competitive cost per sample
Our test kits are fully lyophilised allowing for ease of shipment and can be run on properly calibrated standard real-time instruments.
Our SARS-CoV-2 detection assay is available now for purchase and we have capacity to produce 2m tests per week.
If you’re interested in partnering with us, please contact our sales team.
Customer or technical support
Please email us at: moc.xdmutnauq@troppusremotsuc